These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33434114)

  • 1. The COVID-19 Pandemic and
    Moy L; Bluemke DA
    Radiology; 2021 Mar; 298(3):483-484. PubMed ID: 33434114
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 testing processes and patient protections for resumption of elective surgery.
    Schlosser M; Signorelli H; Gregg W; Korwek K; Sands K
    Am J Surg; 2021 Jan; 221(1):49-52. PubMed ID: 32736801
    [No Abstract]   [Full Text] [Related]  

  • 3. Are T cell repertoires useful as diagnostics for SARS- CoV- 2 infection?
    Harris T; Sauer K
    Expert Rev Mol Diagn; 2021 Feb; 21(2):137-139. PubMed ID: 33595410
    [No Abstract]   [Full Text] [Related]  

  • 4. Is oro/nasopharyngeal swab for SARS-CoV-2 detection a safe procedure? Complications observed among a case series of 4876 consecutive swabs.
    Fabbris C; Cestaro W; Menegaldo A; Spinato G; Frezza D; Vijendren A; Borsetto D; Boscolo-Rizzo P
    Am J Otolaryngol; 2021; 42(1):102758. PubMed ID: 33125901
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 Testing Tests Our Mettle.
    Hefferon KL; St Juliana JR; Miller HI
    Mo Med; 2020; 117(5):417-420. PubMed ID: 33311741
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose chest CT had 95% sensitivity and 91% specificity for diagnosing COVID-19 in patients with clinical symptoms.
    Long B
    Ann Intern Med; 2020 Dec; 173(12):JC68. PubMed ID: 33316180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Modalities for the Detection of SARS-CoV-2: Principles, Advantages, and Pitfalls.
    Anand Bs S; Sujan J; N AK; M I
    Crit Rev Biomed Eng; 2020; 48(4):235-260. PubMed ID: 33463960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 9. Pooled testing with replication as a mass testing strategy for the COVID-19 pandemics.
    Žilinskas J; Lančinskas A; Guarracino MR
    Sci Rep; 2021 Feb; 11(1):3459. PubMed ID: 33568738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 diagnostics: Some reflections on current assays.
    Antonelli G; Stefani S; Pistello M
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115237. PubMed ID: 33130508
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

  • 12. No Time for Complacency: Near-term Impact of the COVID-19 Pandemic on Author Gender in Radiology.
    Robbins JB; Khosa F
    Radiology; 2021 Jul; 300(1):E308-E309. PubMed ID: 33729009
    [No Abstract]   [Full Text] [Related]  

  • 13. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 antibody tests: statistical implications.
    Kankam HK; Hourston GJ; Ravindran P; Azhar B; Pope C
    Br J Hosp Med (Lond); 2020 Nov; 81(11):1-5. PubMed ID: 33263485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 outbreaks in Aotearoa New Zealand: urgent action is required to address systematic causes and consequences of border failures.
    Kvalsvig A; Summers J; Gray L; Telfar-Barnard L; Baker MG
    N Z Med J; 2020 Dec; 133(1527):8-14. PubMed ID: 33332324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What two US counties will tell us about COVID-19.
    Nat Biotechnol; 2021 May; 39(5):533. PubMed ID: 33981080
    [No Abstract]   [Full Text] [Related]  

  • 17. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 18. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
    Gao J; Quan L
    Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.
    Goodhue Meyer EK; Xu M; Lasky B; Young PP
    Transfusion; 2021 Jan; 61(1):330-331. PubMed ID: 33037643
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacist's role in SARS-CoV-2 diagnostic testing.
    Goode JR; Page A; Burns A; Bernard S; Wheawill S; Gatewood SBS
    J Am Pharm Assoc (2003); 2020; 60(6):e19-e32. PubMed ID: 32883622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.